ANP-1

N/A

Report date: 2025/01/26 16:13:34

Base Information

Drug NameANP-1
Drug Alias Nameneuronal progenitor cell therapy (Lineage Cell Therapeutics)ANP-1
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLineage Cell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWilliam Demant Invest A/SLineage Cell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A